The Relationship Between ALA16VAL Single Gene Polymorphism and Renal Cell Carcinoma

Overview

Journal Adv Urol

Publisher Wiley

Specialty Urology

Date 2014 Mar 4

PMID 24587799

Citations 7

Authors

Dogan Atilgan

Bekir S Parlaktas

Nihat Uluocak

Engin Kolukcu

Fikret Erdemir

Huseyin Ozyurt

Unal Erkorkmaz

Affiliations

Soon will be listed here.

Abstract

Objectives. The aim of this study was to investigate the association of RCC and Ala16Val polymorphism in Turkish patients with RCC. Materials and Methods. A total of 41 patients with RCC who underwent radical or partial nephrectomy in our clinic and 50 healthy volunteers living in the same geographic area were included in this study. DNA samples from serum of RCC patients and controls were genotyped for MnSOD polymorphism analysis. Genotype ratios and allele frequencies were compared between two groups and odd ratios with 95% confidence intervals were calculated statistically. A P value of <0.05 was considered statistically significant. Results. There was a significant difference in the MnSOD genotype distributions between the RCC patients and the controls in terms of Ala/Ala+Ala/Val and Val/Val genotypes (P = 0.039). The Ala/Ala+Ala/Val genotypes were found significantly suspicious for RCC with an OR of 2.64 (95% CI = 1.06-6.69, P = 0.039). In addition, Ala allele was found significantly suspicious for RCC with an OR of 2.26 (95% CI = 1.24-4.12, P = 0.009). Conclusion. Our study indicated that MnSOD Ala16Val polymorphism may be one of the many genetic factors for renal cancer susceptibility in Turkish patients.

Citing Articles

Association of SOD2 rs2758339, rs5746136 and rs2842980 polymorphisms with increased risk of breast cancer: a haplotype-based case-control study.

Asadi S, Abkar M, Zamanzadeh Z, Taghipour Kamalabad S, Sedghi M, Yousefnia S Genes Genomics. 2023; 45(9):1165-1178.

PMID: 37253908 DOI: 10.1007/s13258-023-01399-1.

The Association of Polymorphisms in and Genes Involved in Redox Homeostasis in the Development and Progression of Clear Cell Renal Cell Carcinoma.

Mihailovic S, Coric V, Radic T, Savic Radojevic A, Matic M, Dragicevic D Oxid Med Cell Longev. 2021; 2021:6617969.

PMID: 33953831 PMC: 8068539. DOI: 10.1155/2021/6617969.

Association between SOD2 V16A variant and urological cancer risk.

Zhang L, Xu K, Tang B, Zhang W, Yuan W, Yue C Aging (Albany NY). 2020; 12(1):825-843.

PMID: 31929112 PMC: 6977677. DOI: 10.18632/aging.102658.

The SOD Mimic MnTnHex-2-PyP Reduces the Viability and Migration of 786-O Human Renal Cancer Cells.

Costa J, Saraiva N, Batinic-Haberle I, Castro M, Oliveira N, Fernandes A Antioxidants (Basel). 2019; 8(10).

PMID: 31627290 PMC: 6826590. DOI: 10.3390/antiox8100490.

Association between Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls.

Wang P, Zhu Y, Xi S, Li S, Zhang Y Dis Markers. 2018; 2018:3061974.

PMID: 30245752 PMC: 6139213. DOI: 10.1155/2018/3061974.

References

Ergen H, Narter F, Timirci O, Isbir T . Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study. Anticancer Res. 2007; 27(2):1227-30. View

Gago-Dominguez M, Castelao J, Yuan J, Ross R, Yu M . Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control. 2002; 13(3):287-93. DOI: 10.1023/a:1015044518505. View

Mikhak B, Hunter D, Spiegelman D, Platz E, Wu K, Erdman Jr J . Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis. 2008; 29(12):2335-40. PMC: 2722865. DOI: 10.1093/carcin/bgn212. View

Millikan R, Player J, de Cotret A, Moorman P, Pittman G, Vannappagari V . Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res. 2004; 6(4):R264-74. PMC: 468618. DOI: 10.1186/bcr786. View

Valko M, Izakovic M, Mazur M, Rhodes C, Telser J . Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2005; 266(1-2):37-56. DOI: 10.1023/b:mcbi.0000049134.69131.89. View

Clifford S, Prowse A, Affara N, Buys C, Maher E . Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer. 1998; 22(3):200-9. DOI: 10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-#. View

Hu H, Luo M, Du X, Feng Y, Zhang Y, Shen X . Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas. Chin Med J (Engl). 2008; 120(23):2092-8. View

Arsova-Sarafinovska Z, Matevska N, Petrovski D, Banev S, Dzikova S, Georgiev V . Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem Funct. 2008; 26(7):771-7. DOI: 10.1002/cbf.1504. View

Landis S, Murray T, Bolden S, Wingo P . Cancer statistics, 1999. CA Cancer J Clin. 1999; 49(1):8-31, 1. DOI: 10.3322/canjclin.49.1.8. View

10.

Liu G, Zhou W, Park S, Wang L, Miller D, Wain J . The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer. 2004; 101(12):2802-8. DOI: 10.1002/cncr.20716. View

11.

Woodson K, Tangrea J, Lehman T, Modali R, Taylor K, Snyder K . Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control. 2003; 14(6):513-8. DOI: 10.1023/a:1024840823328. View

12.

Kang D, Lee K, Park S, Berndt S, Peters U, Reding D . Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev. 2007; 16(8):1581-6. DOI: 10.1158/1055-9965.EPI-07-0160. View

13.

Hamosh A, King T, Rosenstein B, Corey M, Levison H, Durie P . Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet. 1992; 51(2):245-50. PMC: 1682672. View

14.

Gorman A, McGowan A, Cotter T . Role of peroxide and superoxide anion during tumour cell apoptosis. FEBS Lett. 1997; 404(1):27-33. DOI: 10.1016/s0014-5793(97)00069-0. View

15.

Dasgupta J, Subbaram S, Connor K, Rodriguez A, Tirosh O, Beckman J . Manganese superoxide dismutase protects from TNF-alpha-induced apoptosis by increasing the steady-state production of H2O2. Antioxid Redox Signal. 2006; 8(7-8):1295-305. DOI: 10.1089/ars.2006.8.1295. View

16.

Chuang T, Liu J, Lin C, Tang Y, Yeh M, Chang S . Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy. FEBS Lett. 2007; 581(23):4443-9. DOI: 10.1016/j.febslet.2007.08.021. View

17.

Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F . The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics. 2003; 13(3):145-57. DOI: 10.1097/01.fpc.0000054067.64000.8f. View

18.

Hung R, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D . Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004; 25(6):973-8. DOI: 10.1093/carcin/bgh080. View

19.

Egan K, Thompson P, Titus-Ernstoff L, Moore J, Ambrosone C . MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett. 2003; 199(1):27-33. DOI: 10.1016/s0304-3835(03)00349-5. View

20.

Bergman M, Ahnstrom M, Palmeback Wegman P, Wingren S . Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. J Cancer Res Clin Oncol. 2005; 131(7):439-44. DOI: 10.1007/s00432-004-0663-7. View